Giustarini et al., 2016
KPV appears to exert its effects via the peptide transporter PepT1 rather than classical melanocortin receptors
Moreover, the combination of glucagon with GLP-1 actions could improve WL while protecting against the risk of hyperglycaemia [64]
M., Shimokawa, H., Feletou, M
doi: 10.3389/fimmu.2026.1734880 Received 29 October 2025 Revised 06 March 2026 Accepted 09 March 2026 Published 30 March 2026 Volume 17 - 2026 Edited by Liping Feng, Duke University, United States Reviewed by Akihiro Nakamura, Kyoto Prefectural University of Medicine, Japan Simn Quetzalcoatl Rodrguez-Lara, Tecnologico de Monterrey Campus Puebla, Mexico Updates Copyright 2026 Wang, Wang, Ji, Lou, Yuan, Cui, Xiang and Zhou